ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,652, issued on July 8, was assigned to PeptiDream Inc. (Kanagawa, Japan).
"Hemagglutinin-binding peptide" was invented by Keiichi Masuya (Kawasaki, Japan) and Masaki Ohuchi (Kawasaki, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "[Problem to be solved] To provide a compound having markedly higher antiviral activity than iHA 100, an intermediate for producing the compound, and a medical drug, or the like, containing the high-activity compound above. [Solution] The invention relates to a hemagglutinin-binding peptide, a pharmaceutically acceptable salts, or a solvate thereof, the hemagglutinin-binding peptide being: (1) a polypeptide comprising ...